Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome

Fertility and Sterility

Volumn 80, Issue SUPPL. 2, 2003, Pages 812-819

  Maliqueo, Manuel ^a,c   Clementi, Marisa ^a,d   Gabler, Fernando ^b   Johnson, María Cecilia ^a   Palomino, Alberto ^a   Sir Petermann, Teresa ^c   Vega, Margarita ^a,c  

^a UNIVERSITY OF CHILE   (Chile)

^b San Borja Arriaran Clinical Hospital   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d Prog Latino Americano C   (Mexico)

Author keywords

Apoptosis; Endometrium; Polycystic ovary syndrome; Proliferation; Steroid receptors

Indexed keywords

ANDROGEN RECEPTOR; ANTIGEN; APOPTOSIS INDUCING FACTOR; CASPASE 3; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA FRAGMENT; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; STEROID RECEPTOR;

APOPTOSIS; ARTICLE; CASE CONTROL STUDY; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOMETRIUM CELL; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; NICK END LABELING; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0141740186     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)00987-7     Document Type: Article

References (44)

1. Zawadzky J.K., Dunaif A. Diagnosis criteria: towards a rational approach. Hershmann J.M. Current issues in endocrinology and metabolism. 1992;377-384 Blackwell Scientific Publications, Boston.
2. Franks S. Polycystic ovary syndrome. N Engl J Med. 333:1995;853-861.
3. Nestler J.E. Polycystic ovary syndrome a disorder for a generalist . Fertil Steril. 70:1998;811-812.
4. Dunaif A., Segal K.R., Futterweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1989;1165-1174.
5. Dunaif A. Insulin resistance and the polycystic ovary syndrome mechanism and implications for pathogenesis . Endocrinol Rev. 17:1997;774-800.
6. Sagle M., Bishop K., Ridley N., Alexander F.M., Michel M., Bonney R.C., et al. Recurrent early miscarriage and polycystic ovaries. BMJ. 297:1998;1024-1026.
7. Regan L., Owen E.J., Jacobs H.S. Hypersecretion of luteinizing hormone, infertility, and miscarriage. Lancet. 336:1990;1141-1144.
8. Tulppala M., Stenman U.H., Cacciatore B., Ylikorkala O. Polycystic ovaries and levels of gonadotrophins and androgen in recurrent miscarriage prospective study in 50 women . Br J Obstet Gynaecol. 100:1993;348-352.
9. Coulam C.B., Annegers J.F., Kranz J.S. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol. 61:1983;403-407.
10. Dahlgren E., Johansson S., Lindstedt G., Knutsson F., Oden A., Janson P.O., et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965 a long-term follow-up focusing on natural history and circulating hormones . Fertil Steril. 57:1992;505-513.
11. Segreti E.M. Endometrial hyperplasia and carcinoma in women with androgen excess disorders. Azziz R., Nestler J., Dewailly D. Androgen excess disorders women. 1997;667-672 Lippincott-Raven, Philadelphia.
12. Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update. 7:2001;522-525.
13. Okon M.A., Laird S.M., Tuckermann E.M., Li T.C. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril. 69:1998;682-690.
14. Narukawa S., Kanzari H., Inoue T., Imai K., Higuchi T., Hatayama H., et al. Androgens induce prolactin production by human endometrial stromal cells in vitro. J Clin Endocrinol Metab. 78:1994;165-168.
15. Iwai M., Kanzaki H., Fujimoto M., Kojima K., Hatayama H., Inoue T., et al. Regulation of sex steroid receptor gene expression by progesterone and testosterone in cultured human endometrial stromal cells. J Clin Endocrinol Metab. 80:1995;450-454.
16. Watson H., Franks S., Bonney R.C. Regulation of epidermal growth factor receptor by androgens in human endometrial cells in culture. Hum Reprod. 13:1998;2585-2591.
17. Tuckermann E.M., Okon M.A., Li T., Laird S.M. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril. 74:2000;771-779.
18. Kokawa K., Shikone T., Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab. 81:1996;4144-4147.
19. Vaskivuo T.E., Stenbäck F., Karhumaa P., Risteli J., Dunkel L., Tapanainen J.S. Apoptosis and apoptosis-related proteins in human endometrium. Mol Cell Endocrinol. 165:2000;75-83.
20. Castro A., Johnson M.C., Anido M., Cortinez A., Gabler F., Vega M. Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis. Fertil Steril. 78:2002;587-595.
21. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
22. Thornberry N.A., Labezebnik Y. Caspases enemies within . Science. 281:1998;1312-1316.
23. Critchley H.O., Tong S., Cameron S.T., Drudy T.A., Kelly R.W., Baird D.T. Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo. J Reprod Fertil. 115:1999;389-395.
24. Koh E.A., Illingworth P.J., Duncan W.C., Critchley H.O. Immunolocalization of bcl-2 protein in human endometrium in the menstrual cycle and simulated early pregnancy. Hum Reprod. 10:1995;1557-1562.
25. Adams J., Polson D.W., Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. BMJ. 293:1986;355-359.
26. Noyes R.W., Hertig A.T., Rock J. Dating the endometrial biopsy. Fertil Steril. 1:1950;3-25.
27. Lessey B.A., Killam A.P., Metzger D.A., Haney A.F., Greene G.L., McCarty K.S. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab. 67:1988;334-339.
28. Iñiguez G., Villavicencio A., Gabler F., Palomino A., Vega M. Effect of nitric oxide on the expression of insulin-like growth factors and insulin-like growth factor binding proteins throughout the lifespan of the human corpus luteum. Reproduction. 122:2001;865-873.
29. Brandenberger A.W., Tee M.K., Lee J.Y., Chao V., Jaffe R.B. Tissue distribution of estrogen receptors alpha (ER-α) and (ER-β) mRNA in the midgestational human fetus. J Clin Endocrinol Metab. 82:1997;3509-3512.
30. Tsujimoto Y., Croce C.M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Nat Acad Sci USA. 83:1986;5214-5218.
31. Carmina E., Lobo R.A. Polycystic ovary syndrome (PCOS) arguably the most common endocrinopathy is associated with significant morbidity in women . J Clin Endocrinol Metab. 84:1999;1897-1899.
32. Legro R.S. Polycystic ovary syndrome the new millennium . Mol Cell Endocrinol. 186:2002;219-225.
33. Apparao K.B., Lovely L.P., Gui Y., Lininger R.A., Lessey B.A. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod. 66:2002;297-304.
34. Critchley H.O., Brener R.M., Henderson T.A., Williams K., Nayak N.R., Slayden O.D., et al. Estrogen receptor β, but not estrogen α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab. 86:2001;1370-1378.
35. Lecce G., Meduri G., Ancelin M., Bergeron C., Perrot-Applanat M. Presence of estrogen receptor β in the human endometrium through the cycle expression in glandular, stromal and vascular cells . J Clin Endocrinol Metab. 86:2001;1379-1386.
36. Slayden O.D., Nayak N.R., Burton K.A., Chwalisz K., Cameron S.T., Critchley H.O., et al. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab. 86:2001;2668-2679.
37. Ozanne D.M., Brady M.E., Cook S., Gaughan L., Neal D.E., Robson C.N. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol Endocrinol. 14:2000;1618-1626.
38. Wang T.T., Phang J.M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55:1995;2487-2489.
39. Choi K.C., Kang S.K., Tai C.J., Auersperg N., Leung P.C. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology. 142:2001;2351-2360.
40. Otsuki Y., Misaki O., Sugimoto O., Ito Y., Tsujimoto Y., Akao Y. Cyclic Bcl-2 gene expression in human uterine endometrium during the menstrual cycle. Lancet. 344:1994;28-29.
41. Rogers P.A., Lederman F., Plunkett D., Affandi B. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding. Hum Reprod Suppl. 3:2000;152-161.
42. Ioffe O.B., Papadimitriou J.C., Drachenberg C.B. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium. Hum Pathol. 29:1998;1150-1159.
43. Morsi H.M., Leers M.P., Radespiel-Troger M., Bjorklund V., Kabaraty H.E., Nap M., et al. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium an approach using multiparameter flow cytometry . Gynecol Oncol. 77:2000;11-17.
44. Gibson M. Reproductive health and polycystic ovary syndrome. Am J Med. 98:1995;67S-75S.